Trial Profile
A phase I trial to evaluate the investigative genomic-based diagnostic biomarker VPAC 1 to detect cancers of the breast and prostate
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 08 Oct 2014
Price :
$35
*
At a glance
- Drugs NLS VPAC1 (Primary)
- Indications Breast cancer; Prostate cancer
- Focus Diagnostic use
- 08 Oct 2014 New trial record